News | 19 July 2012
By Lynn Cowan. Early-stage pharmaceutical developer Durata Therapeutics Inc. (DRTX) made modest early trading gains on Thursday, its first day as a public company. The company's stock opened at $10 a share on the Nasdaq, up 11% from its initial public ...
Click on the link to read the full article at Wall Street Journal
(This link will open in a new window)